Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, B. B.
Right arrow Articles by Heiss, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duncan, B. B.
Right arrow Articles by Heiss, G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1799-1805, 2003
© 2003 by the American Diabetes Association, Inc.

Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes

The Atherosclerosis Risk in Communities Study

Bruce B. Duncan1,2, Maria Inês Schmidt1,2, James S. Pankow3, Christie M. Ballantyne4, David Couper5, Alvaro Vigo1, Ron Hoogeveen4, Aaron R. Folsom3, and Gerardo Heiss2

1 Graduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
2 Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina
3 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota
4 Department of Medicine, Baylor College of Medicine, Houston, Texas
5 Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, North Carolina

To examine the association of low-grade systemic inflammation with diabetes, as well as its heterogeneity across subgroups, we designed a case-cohort study representing the ~9-year experience of 10,275 Atherosclerosis Risk in Communities Study participants. Analytes were measured on stored plasma of 581 incident cases of diabetes and 572 noncases. Statistically significant hazard ratios of developing diabetes for those in the fourth (versus first) quartile of inflammation markers, adjusted for age, sex, ethnicity, study center, parental history of diabetes, and hypertension, ranged from 1.9 to 2.8 for sialic acid, orosomucoid, interleukin-6, and C-reactive protein. After additional adjustment for BMI, waist-to-hip ratio, and fasting glucose and insulin, only the interleukin-6 association remained statistically significant (HR = 1.6, 1.01–2.7). Exclusion of GAD antibody-positive individuals changed associations minimally. An overall inflammation score based on these four markers plus white cell count and fibrinogen predicted diabetes in whites but not African Americans (interaction P = 0.005) and in nonsmokers but not smokers (interaction P = 0.13). The fully adjusted hazard ratio comparing white nonsmokers with score extremes was 3.7 (P for linear trend = 0.008). In conclusion, a low-grade inflammation predicts incident type 2 diabetes. The association is absent in smokers and African-Americans.

Address correspondence and reprint requests to Dr. Bruce B. Duncan, Graduate Studies Program in Epidemiology, UFRGS, Av. Luiz Manoel Gonzaga, 630/8, Porto Alegre, RS 90470-280 Brazil. E-mail: bbduncan{at}orion.ufrgs.br


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
R. L. Austin, A. Rune, K. Bouzakri, J. R. Zierath, and A. Krook
siRNA-Mediated Reduction of Inhibitor of Nuclear Factor-{kappa}B Kinase Prevents Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance in Human Skeletal Muscle
Diabetes, August 1, 2008; 57(8): 2066 - 2073.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. H. Golden, M. Lazo, M. Carnethon, A. G. Bertoni, P. J. Schreiner, A. V. D. Roux, H. B. Lee, and C. Lyketsos
Examining a Bidirectional Association Between Depressive Symptoms and Diabetes
JAMA, June 18, 2008; 299(23): 2751 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. M. Nelson, N. Sattar, D. J. Freeman, J. D. Walker, and R. S. Lindsay
Inflammation and Endothelial Activation Is Evident at Birth in Offspring of Mothers With Type 1 Diabetes
Diabetes, November 1, 2007; 56(11): 2697 - 2704.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Conen, P. M Ridker, S. Mora, J. E. Buring, and R. J. Glynn
Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
Eur. Heart J., October 9, 2007; (2007) ehm400v1.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. Liu, L. Tinker, Y. Song, N. Rifai, D. E. Bonds, N. R. Cook, G. Heiss, B. V. Howard, G. S. Hotamisligil, F. B. Hu, et al.
A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women
Arch Intern Med, August 13, 2007; 167(15): 1676 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. Porrini, M. D. Gomez, A. Alvarez, M. Cobo, J. M. Gonzalez-Posada, L. Perez, L. Hortal, J. J. Garcia, M. Dolores Checa, A. Morales, et al.
Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1994 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2017 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. C. O'Connor, C. L. Sherry, C. B. Guest, and G. G. Freund
Type 2 Diabetes Impairs Insulin Receptor Substrate-2-Mediated Phosphatidylinositol 3-Kinase Activity in Primary Macrophages to Induce a State of Cytokine Resistance to IL-4 in Association with Overexpression of Suppressor of Cytokine Signaling-3
J. Immunol., June 1, 2007; 178(11): 6886 - 6893.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. C. Gormsen, N. Jessen, J. Gjedsted, S. Gjedde, H. Norrelund, S. Lund, J. S. Christiansen, S. Nielsen, O. Schmitz, and N. Moller
Dose-Response Effects of Free Fatty Acids on Glucose and Lipid Metabolism during Somatostatin Blockade of Growth Hormone and Insulin in Humans
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1834 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. G. Wannamethee, G. D.O. Lowe, A. Rumley, L. Cherry, P. H. Whincup, and N. Sattar
Adipokines and Risk of Type 2 Diabetes in Older Men
Diabetes Care, May 1, 2007; 30(5): 1200 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. L. Jehn, E. Guallar, J. M. Clark, D. Couper, B. B. Duncan, C. M. Ballantyne, R. C. Hoogeveen, Z. L. Harris, and J. S. Pankow
A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Am. J. Epidemiol., May 1, 2007; 165(9): 1047 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. Thorand, J. Baumert, H. Kolb, C. Meisinger, L. Chambless, W. Koenig, and C. Herder
Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Diabetes Care, April 1, 2007; 30(4): 854 - 860.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Bouzakri and J. R. Zierath
MAP4K4 Gene Silencing in Human Skeletal Muscle Prevents Tumor Necrosis Factor-{alpha}-induced Insulin Resistance
J. Biol. Chem., March 16, 2007; 282(11): 7783 - 7789.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Taudorf, K. S. Krabbe, R. M. G. Berg, B. K. Pedersen, and K. Moller
Human Models of Low-Grade Inflammation: Bolus versus Continuous Infusion of Endotoxin
Clin. Vaccine Immunol., March 1, 2007; 14(3): 250 - 255.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Dehghan, I. Kardys, M. P.M. de Maat, A. G. Uitterlinden, E. J.G. Sijbrands, A. H. Bootsma, T. Stijnen, A. Hofman, M. T. Schram, and J. C.M. Witteman
Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes
Diabetes, March 1, 2007; 56(3): 872 - 878.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. W. Asmann, C. S. Stump, K. R. Short, J. M. Coenen-Schimke, Z. Guo, M. L. Bigelow, and K. S. Nair
Skeletal Muscle Mitochondrial Functions, Mitochondrial DNA Copy Numbers, and Gene Transcript Profiles in Type 2 Diabetic and Nondiabetic Subjects at Equal Levels of Low or High Insulin and Euglycemia
Diabetes, December 1, 2006; 55(12): 3309 - 3319.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. A. Nettleton, L. J. Harnack, C. G. Scrafford, P. J. Mink, L. M. Barraj, and D. R. Jacobs Jr.
Dietary Flavonoids and Flavonoid-Rich Foods Are Not Associated with Risk of Type 2 Diabetes in Postmenopausal Women
J. Nutr., December 1, 2006; 136(12): 3039 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
N. P. Paynter, H.-C. Yeh, S. Voutilainen, M. I. Schmidt, G. Heiss, A. R. Folsom, F. L. Brancati, and W. H. L. Kao
Coffee and Sweetened Beverage Consumption and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study
Am. J. Epidemiol., December 1, 2006; 164(11): 1075 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
W. K. Nicholson, K. Asao, F. Brancati, J. Coresh, J. S. Pankow, and N. R. Powe
Parity and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study.
Diabetes Care, November 1, 2006; 29(11): 2349 - 2354.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. C. Elbein, X. Wang, M. A. Karim, B. I. Freedman, D. W. Bowden, A. R. Shuldiner, F. L. Brancati, and W. H. L. Kao
Role of a Proline Insertion in the Insulin Promoter Factor 1 (IPF1) Gene in African Americans With Type 2 Diabetes.
Diabetes, October 1, 2006; 55(10): 2909 - 2914.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. de Rekeneire, R. Peila, J. Ding, L. H. Colbert, M. Visser, R. I. Shorr, S. B. Kritchevsky, L. H. Kuller, E. S. Strotmeyer, A. V. Schwartz, et al.
Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study
Diabetes Care, August 1, 2006; 29(8): 1902 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. Femia, A. Natali, A. L'Abbate, and E. Ferrannini
Coronary Atherosclerosis and Alcohol Consumption: Angiographic and Mortality Data
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1607 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Doi, Y. Kiyohara, M. Kubo, T. Ninomiya, Y. Wakugawa, K. Yonemoto, M. Iwase, and M. Iida
Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population: The Hisayama Study
Diabetes Care, October 1, 2005; 28(10): 2497 - 2500.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Thorand, H. Kolb, J. Baumert, W. Koenig, L. Chambless, C. Meisinger, T. Illig, S. Martin, and C. Herder
Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984-2002
Diabetes, October 1, 2005; 54(10): 2932 - 2938.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath, and B. K. Pedersen
Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation
Diabetes, October 1, 2005; 54(10): 2939 - 2945.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Nareika, L. He, B. A. Game, E. H. Slate, J. J. Sanders, S. D. London, M. F. Lopes-Virella, and Y. Huang
Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-{kappa}B transcriptional activities
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E534 - E542.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
M. M. Chavan, P. D. Kawle, and N. G. Mehta
Increased sialylation and defucosylation of plasma proteins are early events in the acute phase response
Glycobiology, September 1, 2005; 15(9): 838 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H.-C. Yeh, N. M. Punjabi, N.-Y. Wang, J. S. Pankow, B. B. Duncan, and F. L. Brancati
Vital Capacity as a Predictor of Incident Type 2 Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care, June 1, 2005; 28(6): 1472 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Hung, B. M. McQuillan, C. M. L. Chapman, P. L. Thompson, and J. P. Beilby
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1268 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
B. J. Nicklas, T. You, and M. Pahor
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training
Can. Med. Assoc. J., April 26, 2005; 172(9): 1199 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. M. W. Petersen and B. K. Pedersen
The anti-inflammatory effect of exercise
J Appl Physiol, April 1, 2005; 98(4): 1154 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. A. Tataranni and E. Ortega
A Burning Question: Does an Adipokine-Induced Activation of the Immune System Mediate the Effect of Overnutrition on Type 2 Diabetes?
Diabetes, April 1, 2005; 54(4): 917 - 927.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Recasens, A. Lopez-Bermejo, W. Ricart, J. Vendrell, R. Casamitjana, and J. M. Fernandez-Real
An Inflammation Score Is Better Associated with Basal than Stimulated Surrogate Indexes of Insulin Resistance
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 112 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. A. Vazquez, F. Pazos, J. R. Berrazueta, C. Fernandez-Escalante, M. T. Garcia-Unzueta, J. Freijanes, and J. A. Amado
Effects of Changes in Body Weight and Insulin Resistance on Inflammation and Endothelial Function in Morbid Obesity after Bariatric Surgery
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 316 - 322.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Y. Wong, B. B. Duncan, S. H. Golden, R. Klein, D. J. Couper, B. E. K. Klein, L. D. Hubbard, A. R. Sharrett, and M. I. Schmidt
Associations between the Metabolic Syndrome and Retinal Microvascular Signs: The Atherosclerosis Risk in Communities Study
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2949 - 2954.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. B. Duncan, M. I. Schmidt, J. S. Pankow, H. Bang, D. Couper, C. M. Ballantyne, R. C. Hoogeveen, and G. Heiss
Adiponectin and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
Diabetes, September 1, 2004; 53(9): 2473 - 2478.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. D. Kriketos, J. R. Greenfield, P. W. Peake, S. M. Furler, G. S. Denyer, J. A. Charlesworth, and L. V. Campbell
Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects
Diabetes Care, August 1, 2004; 27(8): 2033 - 2040.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. S. Ryan and B. J. Nicklas
Reductions in Plasma Cytokine Levels With Weight Loss Improve Insulin Sensitivity in Overweight and Obese Postmenopausal Women
Diabetes Care, July 1, 2004; 27(7): 1699 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. J.G. Hanley, A. Festa, R. B. D'Agostino, L. E. Wagenknecht, P. J. Savage, R. P. Tracy, M. F. Saad, and S. M. Haffner
Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes: Factor Analysis Using Directly Measured Insulin Sensitivity
Diabetes, July 1, 2004; 53(7): 1773 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, J. R. Gallimore, M. B. Pepys, and L. V. Campbell
Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences
Circulation, June 22, 2004; 109(24): 3022 - 3028.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. B. Hu, J. B. Meigs, T. Y. Li, N. Rifai, and J. E. Manson
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Diabetes, March 1, 2004; 53(3): 693 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. S. Pankow, B. B. Duncan, M. I. Schmidt, C. M. Ballantyne, D. J. Couper, R. C. Hoogeveen, and S. H. Golden
Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care, January 1, 2004; 27(1): 77 - 82.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.